This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hay, C. M.
Right arrow Articles by Walker, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hay, C. M.
Right arrow Articles by Walker, B. D.

 Previous Article  |  Next Article 

Journal of Virology, July 1999, p. 5509-5519, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection

Christine M. Hay,1 Debbie J. Ruhl,1 Nesli O. Basgoz,1 Cara C. Wilson,2 James M. Billingsley,1 Maria Pia DePasquale,1 Richard T. D'Aquila,1 Steven M. Wolinsky,3 John M. Crawford,4 David C. Montefiori,4 and Bruce D. Walker1,*

Partners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital, Boston, Massachusetts 021141; Infectious Disease Division, University of Colorado Health Sciences Center, Denver, Colorado 802622; Infectious Disease Division, Department of Medicine, Northwestern University School of Medicine, Chicago, Illinois 606113; and Center for AIDS Research and Department of Surgery, Duke University Medical Center, Durham, North Carolina 277104

Received 21 September 1998/Accepted 19 March 1999

Human immunodeficiency virus type 1 (HIV-1)-specific immune responses over the course of rapidly progressive infection are not well defined. Detailed longitudinal analyses of neutralizing antibodies, lymphocyte proliferation, in vivo-activated and memory cytotoxic T-lymphocyte (CTL) responses, and viral sequence variation were performed on a patient who presented with acute HIV-1 infection, developed an AIDS-defining illness 13 months later, and died 45 months after presentation. Neutralizing-antibody responses remained weak throughout, and no HIV-1-specific lymphocyte proliferative responses were seen even early in the disease course. Strong in vivo-activated CTL directed against Env and Pol epitopes were present at the time of the initial drop in viremia but were quickly lost. Memory CTL against Env and Pol epitopes were detected throughout the course of infection; however, these CTL were not activated in vivo. Despite an initially narrow CTL response, new epitopes were not targeted as the disease progressed. Viral sequencing showed the emergence of variants within the two targeted CTL epitopes; however, viral variants within the immunodominant Env epitope were well recognized by CTL, and there was no evidence of viral escape from immune system detection within this epitope. These data demonstrate a narrowly directed, static CTL response in a patient with rapidly progressive disease. We also show that disease progression can occur in the presence of persistent memory CTL recognition of autologous epitopes and in the absence of detectable escape from CTL responses, consistent with an in vivo defect in activation of CTL.


* Corresponding author. Mailing address: Partners AIDS Research Center, MGH-East, 149 13th St., Room 5212D, Charlestown, MA 02129. Phone: (617) 724-8332. Fax: (617) 726-4691. E-mail: bwalker{at}helix.mgh.harvard.edu.


Journal of Virology, July 1999, p. 5509-5519, Vol. 73, No. 7
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Duda, A., Lee-Turner, L., Fox, J., Robinson, N., Dustan, S., Kaye, S., Fryer, H., Carrington, M., McClure, M., Mclean, A. R., Fidler, S., Weber, J., Phillips, R. E., Frater, A. J., and the SPARTAC Trial Investigators, (2009). HLA-Associated Clinical Progression Correlates with Epitope Reversion Rates in Early Human Immunodeficiency Virus Infection. J. Virol. 83: 1228-1239 [Abstract] [Full Text]  
  • Liu, Y., McNevin, J., Zhao, H., Tebit, D. M., Troyer, R. M., McSweyn, M., Ghosh, A. K., Shriner, D., Arts, E. J., McElrath, M. J., Mullins, J. I. (2007). Evolution of Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitopes: Fitness-Balanced Escape. J. Virol. 81: 12179-12188 [Abstract] [Full Text]  
  • McKinnon, L. R., Ball, T. B., Wachihi, C., McLaren, P. J., Waruk, J. L. M., Mao, X., Ramdahin, S., Anzala, A. O., Kamene, J., Luo, M., Fowke, K. R., Plummer, F. A. (2007). Epitope Cross-Reactivity Frequently Differs between Central and Effector Memory HIV-Specific CD8+ T Cells. J. Immunol. 178: 3750-3756 [Abstract] [Full Text]  
  • Nilsson, J., Boasso, A., Velilla, P. A., Zhang, R., Vaccari, M., Franchini, G., Shearer, G. M., Andersson, J., Chougnet, C. (2006). HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108: 3808-3817 [Abstract] [Full Text]  
  • Allen, T. M., Altfeld, M., Geer, S. C., Kalife, E. T., Moore, C., O'Sullivan, K. M., DeSouza, I., Feeney, M. E., Eldridge, R. L., Maier, E. L., Kaufmann, D. E., Lahaie, M. P., Reyor, L., Tanzi, G., Johnston, M. N., Brander, C., Draenert, R., Rockstroh, J. K., Jessen, H., Rosenberg, E. S., Mallal, S. A., Walker, B. D. (2005). Selective Escape from CD8+ T-Cell Responses Represents a Major Driving Force of Human Immunodeficiency Virus Type 1 (HIV-1) Sequence Diversity and Reveals Constraints on HIV-1 Evolution. J. Virol. 79: 13239-13249 [Abstract] [Full Text]  
  • Borkow, G., Bentwich, Z. (2004). Chronic Immune Activation Associated with Chronic Helminthic and Human Immunodeficiency Virus Infections: Role of Hyporesponsiveness and Anergy. Clin. Microbiol. Rev. 17: 1012-1030 [Abstract] [Full Text]  
  • Draenert, R., Verrill, C. L., Tang, Y., Allen, T. M., Wurcel, A. G., Boczanowski, M., Lechner, A., Kim, A. Y., Suscovich, T., Brown, N. V., Addo, M. M., Walker, B. D. (2004). Persistent Recognition of Autologous Virus by High-Avidity CD8 T Cells in Chronic, Progressive Human Immunodeficiency Virus Type 1 Infection. J. Virol. 78: 630-641 [Abstract] [Full Text]  
  • Hirsch, V. M., Santra, S., Goldstein, S., Plishka, R., Buckler-White, A., Seth, A., Ourmanov, I., Brown, C. R., Engle, R., Montefiori, D., Glowczwskie, J., Kunstman, K., Wolinsky, S., Letvin, N. L. (2004). Immune Failure in the Absence of Profound CD4+ T-Lymphocyte Depletion in Simian Immunodeficiency Virus-Infected Rapid Progressor Macaques. J. Virol. 78: 275-284 [Abstract] [Full Text]  
  • Yang, O. O., Sarkis, P. T. N., Ali, A., Harlow, J. D., Brander, C., Kalams, S. A., Walker, B. D. (2003). Determinants of HIV-1 Mutational Escape From Cytotoxic T Lymphocytes. JEM 197: 1365-1375 [Abstract] [Full Text]  
  • Boaz, M. J., Waters, A., Murad, S., Easterbrook, P. J., Vyakarnam, A. (2002). Presence of HIV-1 Gag-Specific IFN-{gamma}+IL-2+ and CD28+IL-2+ CD4 T Cell Responses Is Associated with Nonprogression in HIV-1 Infection. J. Immunol. 169: 6376-6385 [Abstract] [Full Text]  
  • Boissonnas, A., Bonduelle, O., Antzack, A., Lone, Y.-C., Gache, C., Debre, P., Autran, B., Combadiere, B. (2002). In Vivo Priming Of HIV-Specific CTLs Determines Selective Cross-Reactive Immune Responses Against Poorly Immunogenic HIV-Natural Variants. J. Immunol. 169: 3694-3699 [Abstract] [Full Text]  
  • Caulfield, M. J., Wang, S., Smith, J. G., Tobery, T. W., Liu, X., Davies, M.-E., Casimiro, D. R., Fu, T.-M., Simon, A., Evans, R. K., Emini, E. A., Shiver, J. (2002). Sustained Peptide-Specific Gamma Interferon T-Cell Response in Rhesus Macaques Immunized with Human Immunodeficiency Virus gag DNA Vaccines. J. Virol. 76: 10038-10043 [Abstract] [Full Text]  
  • Moore, C. B., John, M., James, I. R., Christiansen, F. T., Witt, C. S., Mallal, S. A. (2002). Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level. Science 296: 1439-1443 [Abstract] [Full Text]  
  • Islam, S. A., Hay, C. M., Hartman, K. E., He, S., Shea, A. K., Trocha, A. K., Dynan, M. J., Reshamwala, N., Buchbinder, S. P., Basgoz, N. O., Kalams, S. A. (2001). Persistence of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T-Lymphocyte Clones in a Subject with Rapid Disease Progression. J. Virol. 75: 4907-4911 [Abstract] [Full Text]  
  • Wilson, C. C., Palmer, B., Southwood, S., Sidney, J., Higashimoto, Y., Appella, E., Chesnut, R., Sette, A., Livingston, B. D. (2001). Identification and Antigenicity of Broadly Cross-Reactive and Conserved Human Immunodeficiency Virus Type 1-Derived Helper T-Lymphocyte Epitopes. J. Virol. 75: 4195-4207 [Abstract] [Full Text]  
  • Hogan, C. M., Hammer, S. M. (2001). Host Determinants in HIV Infection and Disease: Part 1: Cellular and Humoral Immune Responses. ANN INTERN MED 134: 761-776 [Abstract] [Full Text]  
  • Goulder, P. J.R., Tang, Y., Brander, C., Betts, M. R., Altfeld, M., Annamalai, K., Trocha, A., He, S., Rosenberg, E. S., Ogg, G., O'Callaghan, C. A., Kalams, S. A., McKinney, R. E. Jr., Mayer, K., Koup, R. A., Pelton, S. I., Burchett, S. K., McIntosh, K., Walker, B. D. (2000). Functionally Inert HIV-Specific Cytotoxic T Lymphocytes Do Not Play a Major Role in Chronically Infected Adults and Children. JEM 192: 1819-1832 [Abstract] [Full Text]  
  • Ostrowski, M. A., Justement, S. J., Ehler, L., Mizell, S. B., Lui, S., Mican, J., Walker, B. D., Thomas, E. K., Seder, R., Fauci, A. S. (2000). The Role of CD4+ T Cell Help and CD40 Ligand in the In Vitro Expansion of HIV-1-Specific Memory Cytotoxic CD8+ T Cell Responses. J. Immunol. 165: 6133-6141 [Abstract] [Full Text]  
  • Beaumont, T., Broersen, S., van Nuenen, A., Huisman, H. G., de Roda Husman, A.-M., Heeney, J. L., Schuitemaker, H. (2000). Increased Neutralization Sensitivity and Reduced Replicative Capacity of Human Immunodeficiency Virus Type 1 after Short-Term In Vivo or In Vitro Passage through Chimpanzees. J. Virol. 74: 7699-7707 [Abstract] [Full Text]  
  • Grivel, J.-C., Malkevitch, N., Margolis, L. (2000). Human Immunodeficiency Virus Type 1 Induces Apoptosis in CD4+ but Not in CD8+ T Cells in Ex Vivo-Infected Human Lymphoid Tissue. J. Virol. 74: 8077-8084 [Abstract] [Full Text]  
  • Goulder, P. J. R., Brander, C., Annamalai, K., Mngqundaniso, N., Govender, U., Tang, Y., He, S., Hartman, K. E., O'Callaghan, C. A., Ogg, G. S., Altfeld, M. A., Rosenberg, E. S., Cao, H., Kalams, S. A., Hammond, M., Bunce, M., Pelton, S. I., Burchett, S. A., McIntosh, K., Coovadia, H. M., Walker, B. D. (2000). Differential Narrow Focusing of Immunodominant Human Immunodeficiency Virus Gag-Specific Cytotoxic T-Lymphocyte Responses in Infected African and Caucasoid Adults and Children. J. Virol. 74: 5679-5690 [Abstract] [Full Text]  
  • Goulder, P. J. R., Tang, Y., Pelton, S. I., Walker, B. D. (2000). HLA-B57-Restricted Cytotoxic T-Lymphocyte Activity in a Single Infected Subject toward Two Optimal Epitopes, One of Which Is Entirely Contained within the Other. J. Virol. 74: 5291-5299 [Abstract] [Full Text]  
  • Lechner, F., Wong, D. K.H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., Walker, B. D. (2000). Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus. JEM 191: 1499-1512 [Abstract] [Full Text]  
  • Brander, C., Yang, O. O., Jones, N. G., Lee, Y., Goulder, P., Johnson, R. P., Trocha, A., Colbert, D., Hay, C., Buchbinder, S., Bergmann, C. C., Zweerink, H. J., Wolinsky, S., Blattner, W. A., Kalams, S. A., Walker, B. D. (1999). Efficient Processing of the Immunodominant, HLA-A*0201-Restricted Human Immunodeficiency Virus Type 1 Cytotoxic T-Lymphocyte Epitope despite Multiple Variations in the Epitope Flanking Sequences. J. Virol. 73: 10191-10198 [Abstract] [Full Text]